178 related articles for article (PubMed ID: 25996952)
61. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract][Full Text] [Related]
62. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Vadakekolathu J; Al-Juboori SIK; Johnson C; Schneider A; Buczek ME; Di Biase A; Pockley AG; Ball GR; Powe DG; Regad T
Cell Death Dis; 2018 Mar; 9(3):344. PubMed ID: 29497041
[TBL] [Abstract][Full Text] [Related]
63. Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.
Jiang M; Wang Q; Yu G; Wan J; Liu S; Zhang Z; Le A
Int J Lab Hematol; 2021 Aug; 43(4):693-698. PubMed ID: 33372415
[TBL] [Abstract][Full Text] [Related]
64. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
Grandits AM; Wieser R
Exp Hematol; 2021 Jul; 99():1-11. PubMed ID: 34029637
[TBL] [Abstract][Full Text] [Related]
65. A potential new biomarker in HNSCC: metastasis suppressor protein 1 (MTSS1).
Klein M; Wermker K; Rashad A; Fischer HJ; Jonigk DD; Hölzle F; Cacchi C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; 137(4):391-401. PubMed ID: 38443233
[TBL] [Abstract][Full Text] [Related]
66. Metastasis suppressor 1 regulates neurite outgrowth in primary neuron cultures.
Yu J; Lin S; Wang M; Liang L; Zou Z; Zhou X; Wang M; Chen P; Wang Y
Neuroscience; 2016 Oct; 333():123-31. PubMed ID: 27401056
[TBL] [Abstract][Full Text] [Related]
67. Next-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208.
Tron AE; Keeton EK; Ye M; Casas-Selves M; Chen H; Dillman KS; Gale RE; Stengel C; Zinda M; Linch DC; Lai Z; Khwaja A; Huszar D
Leuk Lymphoma; 2016 Dec; 57(12):2927-2929. PubMed ID: 27189703
[No Abstract] [Full Text] [Related]
68. Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1.
Dawson JC; Bruche S; Spence HJ; Braga VM; Machesky LM
PLoS One; 2012; 7(3):e31141. PubMed ID: 22479308
[TBL] [Abstract][Full Text] [Related]
69. Metastasis suppressor 1 interacts with protein tyrosine phosphatase receptor-δ to regulate adipogenesis.
Chen M; Dong Y; Tian L; Zhou J; Zhu E; Yuan H; Li X; Wang B
FASEB J; 2023 Apr; 37(4):e22857. PubMed ID: 36906292
[TBL] [Abstract][Full Text] [Related]
70. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
[TBL] [Abstract][Full Text] [Related]
71. Mtss1 promotes maturation and maintenance of cerebellar neurons via splice variant-specific effects.
Sistig T; Lang F; Wrobel S; Baader SL; Schilling K; Eiberger B
Brain Struct Funct; 2017 Aug; 222(6):2787-2805. PubMed ID: 28214917
[TBL] [Abstract][Full Text] [Related]
72. The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.
Zabkiewicz J; Pearn L; Hills RK; Morgan RG; Tonks A; Burnett AK; Darley RL
Haematologica; 2014 May; 99(5):858-64. PubMed ID: 24334295
[TBL] [Abstract][Full Text] [Related]
73. Mtss1
Fahrenkamp D; Herrmann O; Koschmieder S; Brümmendorf TH; Schemionek M
Leukemia; 2017 Apr; 31(4):1017-1019. PubMed ID: 28167834
[No Abstract] [Full Text] [Related]
74. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia.
Ge Y; Schuster MB; Pundhir S; Rapin N; Bagger FO; Sidiropoulos N; Hashem N; Porse BT
Nat Commun; 2019 Jan; 10(1):172. PubMed ID: 30635567
[TBL] [Abstract][Full Text] [Related]
75. Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control.
Petrov P; Sarapulov AV; Eöry L; Scielzo C; Scarfò L; Smith J; Burt DW; Mattila PK
Sci Rep; 2019 Mar; 9(1):4155. PubMed ID: 30858428
[TBL] [Abstract][Full Text] [Related]
76. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells.
Mustafa N; Martin TA; Jiang WG
Exp Ther Med; 2011 Jan; 2(1):157-162. PubMed ID: 22977484
[TBL] [Abstract][Full Text] [Related]
77. Atypical basophilia.
Boiten HJ; de Jongh E
Blood; 2018 Aug; 132(5):551. PubMed ID: 30072416
[No Abstract] [Full Text] [Related]
78. Cardioprotective Effects of MTSS1 Enhancer Variants.
Morley MP; Wang X; Hu R; Brandimarto J; Tucker NR; Felix JF; Smith NL; van der Harst P; Ellinor PT; Margulies KB; Musunuru K; Cappola TP
Circulation; 2019 Apr; 139(17):2073-2076. PubMed ID: 31070942
[No Abstract] [Full Text] [Related]
79. GPRC5A: A potential tumor suppressor and oncogene.
Acquafreda T; Soprano KJ; Soprano DR
Cancer Biol Ther; 2009 May; 8(10):963-5. PubMed ID: 19593893
[No Abstract] [Full Text] [Related]
80. Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu B; Chen Z; Re TJ; Zheng Q; Tang ZY; Huang XY
J Exp Clin Cancer Res; 2016 Jun; 35(1):102. PubMed ID: 27342210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
